Rockwell Medical (RMTI) Goodwill & Intangibles (2010 - 2026)
Rockwell Medical (RMTI) posted Goodwill & Intangibles of $10.4 million for Q1 2026, down 1.3% on a QoQ basis from $10.6 million in Q4 2025, and down 5.01% year-over-year from $11.0 million in Q1 2025.
Rockwell Medical (RMTI) Goodwill & Intangibles (2010 - 2026) Analysis & Trends
Rockwell Medical's Goodwill & Intangibles history runs 17 years deep, the most recent figure standing at $10.4 million for Q1 2026.
- Quarterly Goodwill & Intangibles fell 5.01% year-over-year to $10.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.4 million (down 5.01% YoY) and the FY2025 annual result came in at $10.6 million, down 4.95% from the prior year.
- Goodwill & Intangibles was $10.4 million for Q1 2026 at Rockwell Medical, down from $10.6 million in the prior quarter.
- Across five years, Goodwill & Intangibles topped out at $11.8 million in Q3 2023 and bottomed at $921000.0 in Q1 2022.
- A 5-year average of $7.5 million and a median of $10.7 million in 2025 frame the typical range for Goodwill & Intangibles.
- Annual changes were most pronounced in 2023 — Goodwill & Intangibles soared 1183.17% — and 2026, when it fell 5.01%.
- Rockwell Medical's Goodwill & Intangibles stood at $921000.0 in 2022, then surged by 1165.91% to $11.7 million in 2023, then decreased by 4.55% to $11.1 million in 2024, then fell by 4.95% to $10.6 million in 2025, then decreased by 1.3% to $10.4 million in 2026.
- Business Quant data shows RMTI's Goodwill & Intangibles at $10.4 million in Q1 2026, $10.6 million in Q4 2025, and $10.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Rockwell Medical | 25.77 Mn | 1.88 Mn | 2.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.44 Mn |
| Dec 31, 2025 | 10.58 Mn |
| Sep 30, 2025 | 10.72 Mn |
| Jun 30, 2025 | 10.85 Mn |
| Mar 31, 2025 | 10.99 Mn |
| Dec 31, 2024 | 11.13 Mn |
| Sep 30, 2024 | 11.27 Mn |
| Jun 30, 2024 | 11.40 Mn |
| Mar 31, 2024 | 11.54 Mn |
| Dec 31, 2023 | 11.66 Mn |
| Sep 30, 2023 | 11.82 Mn |
| Jun 30, 2023 | 921,000.00 |
| Mar 31, 2023 | 921,000.00 |
| Dec 31, 2022 | 921,000.00 |
| Sep 30, 2022 | 921,000.00 |
| Jun 30, 2022 | 921,000.00 |
| Mar 31, 2022 | 921,000.00 |
| Dec 31, 2021 | 900,000.00 |
| Sep 30, 2021 | 921,000.00 |
| Jun 30, 2021 | 921,000.00 |